FPP Announces the Filing of its First Organically Developed ANDA

Friday, February 7, 2020 General News
Email Print This Page Comment bookmark
Font : A-A+

Florida Pharmaceutical Products, LLC, (FPP), a pharmaceutical company involved in the Development, Sales, Marketing, and Distribution of Generic Pharmaceuticals is pleased to announce the filing of its first organically developed ANDA with the FDA. Currently the market for this product has sales of approximately $100 million according to IQVIA™ and limited generic competition.

BOCA RATON, Fla., Feb. 6, 2020 /PRNewswire-PRWeb/ -- The product that was just filed is one of the original pipeline product selections of the founder, the late Larry Runsdorf. "We are excited about this opportunity and happy to bring this project to filing, in honor of what Larry started several years ago," said Larry J. Lapila, President of FPP.

About Florida Pharmaceutical Products, LLC:

Florida Pharmaceutical Products, LLC, (FPP), is a Boca Raton-based pharmaceutical company involved in the development of Generic Pharmaceuticals seeking to gain approval and/or license of niche generic products in a broad range of therapeutic areas for marketing and distribution in the US.

At FPP our mission is to deliver products to improve patients' lives.

 

SOURCE Florida Pharmaceutical Products, LLC



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Diabetes Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store